Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pyruvate kinase is a key glycolytic enzyme that catalyzes the final step of glycolysis: the transfer of a phosphate group from phosphoenolpyruvate (PEP) to adenosine diphosphate (ADP), producing pyruvate and adenosine triphosphate (ATP). The liver and red blood cell isoforms—PKL and PKR—are both encoded by the PKLR gene. Mutations in the PKLR gene can cause pyruvate kinase deficiency—a common cause of hereditary nonspherocytic hemolytic anemia due to impaired ATP production in erythrocytes.
Catalyzes the transfer of a phosphate group from phosphoenolpyruvate (PEP) to adenosine diphosphate (ADP), producing pyruvate and adenosine triphosphate (ATP).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pyruvate Kinase Liver and Red Blood Cell Isoform (None).